MEDSERVREGIS P.L.C financials
MEDSERVREGIS P.L.C
Country: MT Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
2138003WBERIMWQVKZ64 Financial statements
(EUR, as reported — unscaled; 111 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Cost of sales | €50.5M | €54.6M |
| Gross profit | €19.5M | €19.3M |
| Other income | €227.2K | €987.9K |
| Administrative expenses | €13.9M | €13.2M |
| Operating profit (EBIT) | €6.3M | €7.9M |
| Net finance income / (cost) | -€2.4M | -€6.2M |
| Finance costs | €4.2M | €7.2M |
| Profit before tax | €3.9M | €1.7M |
| Income tax expense | €1.8M | €377.4K |
| Profit for the year | €2.1M | €1.3M |
| — attributable to owners | €1.9M | €1.1M |
| — attributable to NCI | €229.2K | €213.3K |
| Total comprehensive income | €1.2M | -€527.8K |
| Per share | ||
| Basic EPS | €0.02 | €0.01 |
| Diluted EPS | €0.02 | €0.01 |
| Free cash flow / share | €0.11 | €0.08 |
| Cash flow statement | ||
| Cash generated from operations | €17.8M | €12.5M |
| Net cash from operating activities | €17.4M | €12.4M |
| Net cash from investing activities | -€3.9M | -€2.9M |
| Purchase of PP&E (capex) | €4.9M | €2.7M |
| Net cash from financing activities | -€9.9M | -€10.3M |
| Dividends paid | €999.2K | €0 |
| Proceeds from borrowings | €1.8M | €7.5M |
| Lease liability payments | €4.4M | €3.8M |
| Net change in cash | €3.6M | -€855.6K |
| Balance sheet | ||
| Total assets | €145.7M | €145.2M |
| Non-current assets | €102.5M | €102.3M |
| Property, plant & equipment | €32.2M | €30.8M |
| Right-of-use assets | €51.7M | €52.3M |
| Intangible assets & goodwill | €14.3M | €15.5M |
| Current assets | €43.3M | €42.9M |
| Inventories | €731.4K | €533.9K |
| Trade & other receivables | €21.4M | €20.7M |
| Cash & equivalents | €17.0M | €13.9M |
| Total equity | €57.6M | €58.1M |
| — attributable to owners | €56.4M | €56.9M |
| Non-controlling interests | €1.2M | €1.2M |
| Non-current liabilities | €69.3M | €69.3M |
| Long-term borrowings | €46.2M | €47.6M |
| Lease liabilities (non-current) | €16.7M | €16.4M |
| Current liabilities | €18.8M | €17.9M |
| Current portion of long-term borrowings | €3.2M | €1.3M |
| Lease liabilities (current) | €3.4M | €3.0M |
| Trade & other payables | €9.3M | €10.9M |
| Deferred tax liabilities | €5.0M | €3.8M |
| Derived metrics | ||
| Free cash flow | €12.5M | €9.7M |
| Operating margin | 9.0% | 10.6% |
| Net margin | 3.0% | 1.8% |
| Return on equity | 3.6% | 2.2% |
| Cash conversion ratio | 8.30× | 9.58× |
| Capex coverage | 3.56× | 4.63× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€152.5K | €163.1K |
| Adjustments For Depreciation and Amortisation Expense | €9.6M | €9.6M |
| Adjustments For Fair Value Gains Losses | -€195.1K | -€441.3K |
| Adjustments For Gain Loss On Disposals Property Plant and Equipment | €138.3K | -€29.6K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Property Plant and Equipment | €146.4K | €78.9K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | €101.0K | €0 |
| Adjustments For Income Tax Expense | €1.8M | €377.4K |
| Adjustments For Interest Expense | €4.2M | €4.2M |
| Adjustments For Interest Income | €450.6K | €1.0M |
| Adjustments For Provisions | €208.1K | €0 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -€969.4K | €2.8M |
| Bank Overdrafts Classified As Cash Equivalents | €2.0M | €2.4M |
| Cash | €19.0M | €16.3M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €16.0M | €16.1M |
| Comprehensive Income Attributable To Noncontrolling Interests | €34.5K | €243.1K |
| Comprehensive Income Attributable To Owners of Parent | €1.1M | -€770.9K |
| Contract Assets | €730.9K | €3.4M |
| Current Contract Liabilities | €218.5K | €113.2K |
| Current Provisions For Employee Benefits | €59.4K | €49.2K |
| Current Tax Assets Current | €953.2K | €430.9K |
| Current Tax Liabilities Current | €472.2K | €105.1K |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | €1.5M | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €0.01 | — |
| Dividends Recognised As Distributions To Owners Per Share | €0.01 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€508.2K | -€3.9M |
| Equity and Liabilities | €145.7M | €145.2M |
| Finance Income | €1.8M | €1.0M |
| Gains Losses On Exchange Differences On Translation Net of Tax | -€525.2K | -€1.8M |
| Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 | -€417.0K | -€762.5K |
| Income Taxes Paid Refund Classified As Operating Activities | €435.7K | €494.5K |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | -€598.6K | — |
| Increase Decrease Through Transactions With Owners | -€1.6M | -€1.8M |
| Interest Paid Classified As Financing Activities | €3.6M | €3.7M |
| Interest Paid Classified As Operating Activities | €123.8K | €115.4K |
| Interest Received Classified As Operating Activities | €349.6K | €488.7K |
| Investments In Associates Accounted For Using Equity Method | €2.3K | €0 |
| Issued Capital Ordinary Shares | €10.2M | €10.2M |
| Liabilities | €88.1M | €87.1M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €304.6K | €0 |
| Noncurrent Financial Assets At Amortised Cost | €899.8K | €0 |
| Noncurrent Financial Assets At Fair Value Through Profit Or Loss | €3.4M | €3.6M |
| Noncurrent Provisions For Employee Benefits | €1.4M | €1.4M |
| Other Comprehensive Income | -€938.6K | -€1.8M |
| Other Comprehensive Income Attributable To Noncontrolling Interests | -€194.7K | €29.7K |
| Other Comprehensive Income Attributable To Owners of Parent | -€743.9K | -€1.9M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €77.5K | €82.9K |
| Other Comprehensive Income Net of Tax Hedges of Net Investments In Foreign Operations | -€523.3K | €305.3K |
| Other Shortterm Provisions | €115.6K | €0 |
| Payments From Changes In Ownership Interests In Subsidiaries | €598.6K | €0 |
| Payments To and On Behalf of Employees | €163.3K | €0 |
| Proceeds From Sales of Investments Other Than Investments Accounted For Using Equity Method | €651.0K | €1.1M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €457.3K | €313.3K |
| Purchase of Interests In Associates | €2.3K | €0 |
| Purchase of Investments Other Than Investments Accounted For Using Equity Method | €157.1K | €1.7M |
| Reclassification Adjustments On Change In Value of Foreign Currency Basis Spreads Before Tax | -€32.4K | €396.5K |
| Repayments of Bonds Notes and Debentures | €987.5K | €7.8M |
| Reserve of Exchange Differences On Translation | -€5.8M | -€4.8M |
| Retained Earnings | €25.6M | €25.1M |
| Revenue From Contracts With Customers | €70.0M | €73.9M |
| Share Premium | €27.8M | €27.8M |
Methodology
Every line item above is a fact tagged in MEDSERVREGIS P.L.C's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.